<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gyori D</submitter><funding>Cancer Research UK</funding><funding>Medical Research Council</funding><funding>Wellcome Trust</funding><funding>Biotechnology and Biological Sciences Research Council</funding><pagination>120631</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6124419</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>3(11)</volume><pubmed_abstract>Redundancy and compensation provide robustness to biological systems but may contribute to therapy resistance. Both tumor-associated macrophages (TAMs) and Foxp3+ regulatory T (Treg) cells promote tumor progression by limiting antitumor immunity. Here we show that genetic ablation of CSF1 in colorectal cancer cells reduces the influx of immunosuppressive CSF1R+ TAMs within tumors. This reduction in CSF1-dependent TAMs resulted in increased CD8+ T cell attack on tumors, but its effect on tumor growth was limited by a compensatory increase in Foxp3+ Treg cells. Similarly, disruption of Treg cell activity through their experimental ablation produced moderate effects on tumor growth and was associated with elevated numbers of CSF1R+ TAMs. Importantly, codepletion of CSF1R+ TAMs and Foxp3+ Treg</pubmed_abstract><journal>JCI insight</journal><pubmed_title>Compensation between CSF1R+ macrophages and Foxp3+ Treg cells drives resistance to tumor immunotherapy.</pubmed_title><pmcid>PMC6124419</pmcid><funding_grant_id>-C0428</funding_grant_id><funding_grant_id>095198/Z/10/Z</funding_grant_id><funding_grant_id>BBS/E/B/000 -C0407,-C0409,-C0427</funding_grant_id><funding_grant_id>BB/N007794/1</funding_grant_id><funding_grant_id>BB/J004456/1</funding_grant_id><funding_grant_id>C52623/A22597</funding_grant_id><funding_grant_id>1947452</funding_grant_id><funding_grant_id>22597</funding_grant_id><funding_grant_id>BB/E009867/1</funding_grant_id><funding_grant_id>105663/Z/14/Z</funding_grant_id><pubmed_authors>Spensberger D</pubmed_authors><pubmed_authors>Shuttleworth SJ</pubmed_authors><pubmed_authors>Okkenhaug K</pubmed_authors><pubmed_authors>Grant FM</pubmed_authors><pubmed_authors>Roychoudhuri R</pubmed_authors><pubmed_authors>Lim EL</pubmed_authors><pubmed_authors>Stephens LR</pubmed_authors><pubmed_authors>Gyori D</pubmed_authors><pubmed_authors>Hawkins PT</pubmed_authors></additional><is_claimable>false</is_claimable><name>Compensation between CSF1R+ macrophages and Foxp3+ Treg cells drives resistance to tumor immunotherapy.</name><description>Redundancy and compensation provide robustness to biological systems but may contribute to therapy resistance. Both tumor-associated macrophages (TAMs) and Foxp3+ regulatory T (Treg) cells promote tumor progression by limiting antitumor immunity. Here we show that genetic ablation of CSF1 in colorectal cancer cells reduces the influx of immunosuppressive CSF1R+ TAMs within tumors. This reduction in CSF1-dependent TAMs resulted in increased CD8+ T cell attack on tumors, but its effect on tumor growth was limited by a compensatory increase in Foxp3+ Treg cells. Similarly, disruption of Treg cell activity through their experimental ablation produced moderate effects on tumor growth and was associated with elevated numbers of CSF1R+ TAMs. Importantly, codepletion of CSF1R+ TAMs and Foxp3+ Treg</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Jun</publication><modification>2025-04-19T10:56:10.964Z</modification><creation>2019-03-26T23:54:58Z</creation></dates><accession>S-EPMC6124419</accession><cross_references><pubmed>29875321</pubmed><doi>10.1172/jci.insight.120631</doi></cross_references></HashMap>